Skip NavigationSkip to Content
Return Return to Search Results

DNA fingerprinting of the NCI-60 cell line panel

  1. Author:
    Lorenzi, P. L.
    Reinhold, W. C.
    Varma, S.
    Hutchinson, A. A.
    Pommier, Y.
    Chanock, S. J.
    Weinstein, J. N.

  2. Author Address

    Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA. [Lorenzi, Philip L.; Reinhold, William C.; Varma, Sudhir, Pommier, Yves, Weinstein, John N.] NCI, Genom & Bioinformat Grp, Mol Pharmacol Lab, CCR,NIH, Bethesda, MD 20892 USA. [Hutchinson, Amy A.] NCI, Core Genotyping Facil, Div Canc Epidemiol & Genet, Adv Technol Program,SAIC Frederick Inc, Frederick, MD 21701 USA. [Hutchinson, Amy A.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.
    1. Year: 2009
  2. Journal: Molecular Cancer Therapeutics
    1. 8
    2. 4
    3. Pages: 713-724
  4. Type of Article: Article
  1. Abstract:

    The National Cancer Institute's NCI-60 cell line panel, the most extensively characterized set of cells in existence and a public resource, is frequently used as a screening tool for drug discovery. Because many laboratories around the world rely on data from the NCI-60 cells, confirmation of their genetic identities represents an essential step in validating results from them. Given the consequences of cell line contamination or misidentification, quality control measures should routinely include DNA fingerprinting. We have, therefore, used standard DNA microsatellite short tandem repeats to profile the NCI-60, and the resulting DNA fingerprints are provided here as a reference. Consistent with previous reports, the fingerprints suggest that several NCI-60 lines have common origins: the melanoma lines MDA-MB-435, MDA-N, and M14, the central nervous system lines U251 and SNB-19, the ovarian lines OVCAR-8 and OVCAR-8/ADR (also called NCI/ADR); and the prostate lines DU-145, DU-145 (ATCC), and RC0.1. Those lines also show that the ability to connect two fingerprints to the same origin is not affected by stable transfection or by the development of multidrug resistance. As expected, DNA fingerprints were not able to distinguish different tissues-of-origin. The fingerprints serve principally as a barcodes. [Mol Cancer Ther 2009,8(4): 713-24]

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1158/1535-7163.mct-08-0921
  3. PMID: 19372543

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel